| Vol. 14.39 – 13 October, 2023 |
| |
|
|
| Researchers provided insights into regulation of aggressive prostate cancer (PCa) cell behavior by citron kinase (CIT) and identified CIT as a functionally diverse and druggable driver of PCa progression. [Cancer Research] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists comprehensively characterized the effects of androgen receptor blockade on prostate cancer metabolism using transcriptomics, metabolomics, and bioenergetics approaches. [Cell Reports] |
|
|
|
| RNA polymerase mitochondria (POLRMT) is essential for mitochondrial transcription machinery and other mitochondrial functions. Researchers explored its expression and potential functions in prostate cancer. [Cell Death & Disease] |
|
|
|
| RBM14 was found to be a novel factor involved in maintenance of prostate specific antigen expression via phase separation under androgen deprivation in prostate cancer. [Journal of Steroid Biochemistry and Molecular Biology] |
|
|
|
| Using in vitro and in vivo models, investigators showed that GCNT1 promoted the growth of prostate tumors and could modify the glycome of prostate cancer cells. [Scientific Reports] |
|
|
|
| Deletion of 3-phosphoinositide-dependent protein kinase-1 (PDK1) in osteoclasts ameliorated osteolysis and reduced bone resorption markers in the murine model of prostate cancer-induced osteolysis. [European Journal of Medical Research] |
|
|
|
| Investigators showed that pheophorbide-a-photodynamic therapy substantially inhibited cell viability, anchorage-independent growth, and migration capacities and induced autophagy and apoptosis. [Journal of Pharmacy and Pharmacology] |
|
|
|
| The authors investigated the antitumor effect of berbamine, extracted from berberis amurensis, on prostate cancer stem cells. [The Prostate] |
|
|
|
| Researchers evaluated the effects of betanin combined with radiation therapy as a potential radiosensitizing agent in the PC-3 cell line. [Molecular Biology Reports] |
|
|
|
|
| The authors highlight the role of NFATc1 in the progression and metastasis of prostate cancer and summarize the signaling pathways and molecular mechanisms, through which NFATc1 regulates the process of prostate cancer. [Cell Biology International] |
|
|
|
|
| The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announced the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. [UT Health San Antonio] |
|
|
|
|
| November 15 – 17, 2023 Seoul, Korea |
|
|
|
|
|
| University of Alabama at Birmingham – Birmingham, Alabama, United States |
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| Fred Hutchinson Cancer Center – Seattle, Washington, United States |
|
|
|
| Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| Massachusetts General Hospital – Boston, Massachusetts, United States |
|
|
|
|